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Abstract
Background: Since the Helsinki Declaration was introduced in 1964 as a code of practice for clinical
research, it has generally been agreed that research governance is also needed in the field of public health
and health promotion research. Recently, a range of factors led to the development of more stringent
bureaucratic procedures, governing the conduct of low-risk population-based health research in the
United Kingdom.
Methods: Our paper highlights a case study of the application process to medical research ethics
committees in the United Kingdom for a study of the promotion of physical activity by health care
providers. The case study presented here is an illustration of the challenges in conducting low-risk
population-based health research.
Results: Our mixed-methods approach involved a questionnaire survey of and semi-structured interviews
with health professionals (who were all healthy volunteers). Since our study does not involve the
participation of either patients or the general population, one would expect the application to the relevant
research ethics committees to be a formality. This proved not to be the case!
Conclusion: Research ethics committees could be counter-productive, rather than protecting the
vulnerable in the research process, they can stifle low-risk population-based health research. Research
ethics in health services research is first and foremost the responsibility of the researcher(s), and we need
to learn to trust health service researchers again. The burden of current research governance regulation
to address the perceived ethical problems is neither appropriate nor adequate. Senior researchers/
academics need to educate and train students and junior researchers in the area of research ethics, whilst
at the same time reducing pressures on them that lead to unethical research, such as commercial funding,
inappropriate government interference and the pressure to publish.
We propose that non-invasive low-risk population-based health studies such as face-to-face interviews 
with health and social care professionals or postal questionnaire studies with patients on non-sensitive 
topics are given a waiver or a light touch review. We suggest that this can be achieved through a two-
staged ethics application process. The first stage starts with a one or two-page outline application which 
ethics committees can use as the basis to grant a waiver or request a full application.
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There is a general agreement that more and better quality
research is needed to develop evidence in the field of pub-
lic health and health promotion [1]. However, a range of
factors have led to the development of more stringent
bureaucratic procedures, governing the conduct of health
services and health promotion research in the UK [2,3].
These procedures are partly as result of EU (European
Union) legislation for clinical research, such as the Data
Protection Act and Human Rights legislation, and have
resulted in (a) standardization of procedures [4]; and (b)
additional challenges in conducting low-risk population-
based health research [5]. At a more abstract level some
have argued that the increased 'control' of health research
is part of a trend in society, which as a whole is becoming
more risk averse [6,7].
Our paper highlights a case study of the application proc-
ess to medical research ethics committees in the UK for a
study of the promotion of physical activity by health care
providers [8]. Our case study in public health presented
here is an illustration of the challenges in conducting pub-
lic low-risk population-based health research in the UK.
Our mixed-methods study consisted of a questionnaire
survey of and semi-structured interviews with primary
care professionals. All professional were volunteers and as
we did not conduct research with the general population,
one would expect the application to the research ethics
committees to be a formality. Before we introduce our
case study we will consider the origins of medical and
health research ethics committees.
Origins of research ethics committees
In 1964 the World Medical Association drew up the first
Declaration of Helsinki (see most up-to-date version at
http://www.wma.net/e/policy/b3.htm), the most widely
accepted guidance on biomedical research on humans; its
key principles are listed in Table 1. This Declaration was a
response to medical experiments conducted on prisoners
in Nazi concentration camps across Europe during the
Holocaust [9,10], as came to light during the Nuremburg
trials. It is now generally accepted that research partici-
pants have a right to expect that the research is conducted
to appropriate standards, and adds something to the body
of knowledge as highlighted in the Nuremburg Code of
1947. Although serious research misconduct is relatively
rare, the exceptions remind us that vigilance is always
required, especially because misconduct can be hard to
prove [11]. One of the textbook examples of serious
health services research misconduct is the Tuskegee Syph-
ilis Study [10]. Between 1932 and 1972 researchers in a
long-term study regularly examined a large number of
poor African Americans in Alabama (USA), suffering from
syphilis, to study the natural course of the disease [12].
These men were made to believe that they were receiving
proper medical treatment when, in fact, either no treat-
ment or inadequate treatment was given.
These extreme cases highlight why we need a public body
to protect the general population from unethical research.
In the Declaration of Helsinki, the World Medical Associ-
ation [13] outlined that a research protocol "should be
submitted for consideration, comment, guidance, and
where appropriate, approval to a specially appointed eth-
ical review committee, which must be independent of the
investigator, the sponsor or any other kind of undue influ-
ence." The reply in the USA has been the establishment of
IRBs (Institutional Review Boards) at universities and
research institutes, whilst the UK originally went down
the path of local NHS (National Health Service) research
ethics committees (REC), although many British universi-
ties have began to establish their own RECs for health
research conducted outwith the NHS. For example, the
one for our own university was established in 2008.
There have been considerable changes in the past decade
in the rules and regulations governing applications for
ethical approval to conduct low-risk population-based
health research in the UK [14]. New national research gov-
ernance frameworks are intended to improve the research
process. These changes are supposed to make applying for
research ethics permission more transparent, with a
greater emphasis on ethical considerations for researchers.
In practice, the changes introduced in the past few years
have made the process of applying for ethical approval
more time-consuming, complex, and bureaucratic [15-
17]. The standard application form for MRECs (Multicen-
tre Research Ethics Committees) and/or local RECs is long
and fairly complicated. For example, the NHS REC appli-
cation form in use in the summer of 2007 was 80-odd
pages long, and some point in 2005 it was as long as 96
pages.
This paper reports on the process of applying for research
ethics approval for a relatively straightforward, unobtru-
sive, non-interventionist health promotion study. It high-
lights some of the oddities of the current UK system, and
the potential impact on the ability to conduct good qual-
ity health promotion and health education research in the
future. We suggest some improvements to the current sys-
Table 1: The four key ethical principles
Do no harm/non-maleficence
Do good/beneficence
Justice
Respect for autonomyPage 2 of 7
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health and health promotion research, which are based
on principles of pragmatism, consistency and efficiency,
as well as the four key principles listed in Table 1
Ethics committees in the UK
In the UK health service, clinical, health care, public
health, nursing, epidemiological, and health promotion
research must be considered under general biomedical
research ruling [18]. Each region has one or more separate
research ethics committees which operate independently
from the local universities and health-care providers. A
national body called COREC (Central Office for Research
Ethics Committees), was established by the UK Govern-
ment to oversee all the area-based research ethics commit-
tees. This was replaced in 2008 by the National Research
Ethics Service (NRES) run by the NHS National Patient
Safety Agency http://www.nres.npsa.nhs.uk/. Therefore,
anybody conducting research in the UK on NHS premises,
with NHS patients and/or NHS staff has to apply to such
a committee. In theory then all applications nationwide
are assessed by the same criteria by a similar committee. It
is universally accepted that a team of doctors wishing to
conduct a clinical trial of a pharmaceutical drug with
potentially dangerous side effects must apply for appro-
priate ethical approval. However, it is also the case that
social or health researchers planning a study, of for exam-
ple, NHS hospital porters' attitudes towards cycling to
work must apply to the same research ethics committee.
There are around 200 local RECs in the UK, each with a
mixture of between 10 to 20 (lay and professional) mem-
bers [19]. The remit of a research ethics committee is "to
protect the rights, safety, dignity and well being of all
actual or potential participants" [20]. The role of each
committee is to assess the potential ethical implications of
the proposed research as outlined on the application
form, the study protocol. In addition the study materials
are considered, for example, the participants' information
sheets, letters inviting people to participate in a study,
posters to recruit interviewees in a clinical setting and any
other items submitted. The process of applying for ethical
approval is widely considered to be a lengthy, bureau-
cratic one [21]. If a research project fails to receive ethical
approval the proposed research should not go ahead until
a revised proposal which addresses the concerns of the
REC is accepted.
Problems have arisen in this system when researchers
have looked to conduct a nationwide study or a study
involving participants from more than one region. Hence
Multi-centre Research Ethics Committees (MRECs) were
introduced to avoid researchers having to apply to several
local RECs with the same application [18,22]. At the time
of our study a two tier-system existed, whereby MRECs, as
overarching ethics committees, considered the key ethical
issues of the proposed research, whilst the second tier, the
RECs, considered specific local issues, such as, for exam-
ple, the number of studies already running locally in the
same patient population in order to avoid overburdening
these participants.
Over the past two decades there has been much criticism
from the research community (and not just in Public
Health) on the way RECs operate in the UK [4,15-17,23-
30]. Barker, for example, describes an epidemiological
study of a pre-NHS archive of health visitors' records
babies living in Hertfordshire (UK) [31]. Based on these
records Barker and his team conducted a long-term epide-
miological follow study of 15,000 people some 50 years
later. His final comment is highly relevant here:
At the time we had no difficulty in getting permission
to trace, interview, and examine large numbers of peo-
ple. It is unlikely that such permission would be so
readily obtained today. Had current data protection
laws been in force 15 years ago, they might have pre-
vented thousands of willing Hertfordshire people
from taking part in medical research-and the fetal ori-
gins hypothesis would not exist [32].
Of course, the RECs system is not fail-safe; even with
active ethics committees there is still going to be unethical
research. For example, having undergone an appropriate
ethical review did not prevent the UK scandal of body
parts of children being kept for research without parents
being informed or asked for permission at Alder Hey Hos-
pital in Liverpool [33]. Whilst the 2006 drug trial at
Northwick Park Hospital (London), that caused serious
side effects in six healthy male volunteers in a private facil-
ity [34], had been reviewed and approved by the appropri-
ate research ethics committee. As Dingwall reminded us,
the relatively regulatory environment in Germany of the
1930s did not prevent the medical experimentations of
the Nazi in the 1940s [34]. So although we are convinced
of the importance of having such ethics committees, it is
clear that they can not (and will not) police all on-going
research to help maintain ethical standards. Therefore, it
is ultimately a key role for researchers to consider the eth-
ical elements of their research (and that of their students),
and to ensure that research is being conducted ethically.
Case study
Our case story highlights an ethics application process
which took place recently (2004) and raises a number of
ethical and practical public health research issues for low-
risk population-based research. We were successful in
winning a research contract (after a competitive tendering
process) to conduct a national study to investigate knowl-
edge, attitudes and current practice amongst primary carePage 3 of 7
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aspect of routine patient consultation. Primary care staff
in this study refers to family doctors/general practitioners
(GPs), health visitors, and practice nurses, and our study
did not involve vulnerable groups, NHS patients, or the
general public [8]. It was solely directed at health care pro-
fessionals.
We planned to use a mixed methods approach, including
a postal questionnaire in four health regions, and inter-
views with a sub-sample of GPs, practice nurses and
health visitors. We aimed to conduct the majority of the
staff interviews by telephone in order to minimise the dis-
ruption to their work time. All interviewees were volun-
teers. The kind of questions asked were not personal in
terms of addressing respondents' life or lifestyle, but
related, for example, to the advice given on physical activ-
ity to their patients/clients. Additional file 1 lists examples
of the kind of questions we addressed to convince the
reader that the questions in questionnaire did not raise
any obvious ethical concerns, neither was there any prob-
ing into health professionals' personal life.
MREC application
The initial ethics application was made to MREC using the
68-page form in use at the time, and endorsement was
granted within six weeks. Although the MREC did not ask
us to change any aspect of our study, it informed us that
we should not start the any part of it until we had LREC
endorsement from the four regional health board areas
concerned.
Having sent the required number copies of the applica-
tion with similar number of copies of supporting docu-
mentation to the MREC, their response letter to us stated
that each local REC should receive a copy of the MREC let-
ter and response form and Part C of the COREC form plus
similar number copies of questionnaire.
The following sections outline the quite different
responses from the four local RECs. We have labeled them
A-D to avoid identification. REC A replied quite quickly
(within three weeks) to inform us that we could proceed
in their area as soon as we wanted. So far, so good.
The second REC took longer to reply (5 weeks) and gave
approval on the basis that they considered there were no
locality issues relating to the application. However, REC B
did draw our attention to minor changes in the study
materials (which the MREC had not commented on);
required us to seek local NHS management approval and
give guarantees on medical indemnity. REC C was experi-
encing an organisational restructuring at the time and
after some negotiating, the acting Director of Public
Health granted management approval for the study to go
ahead on the basis that MREC approval had already been
granted.
We had to follow-up REC D as we had received no com-
munication after two months. Our prompting resulted in
a letter explaining that one of the committee members
had concerns about confidentiality and anonymity issues
and storage of data – an issue which had not been raised
by MREC, whose primary role (distinct from the LREC) is
to assess all ethical issues in our multicentre study. In
addition, we were required to gain the endorsement of the
local Primary Health Care Trusts Research & Development
committee. Such committee manages all research with
implications for the NHS. REC D also insisted on receiv-
ing a copy of our final report. In addition to sending the
documentation as advised by MREC (see above), we were
also required to submit copies of the CVs of all research-
ers, a copy of the study protocol, the REC letter and our
response regarding their concerns about confidentiality.
Additionally we were required to complete and sign a
Data Protection Checklist.
In the end we gained all the necessary approval from all
four RECs five months after lodging the original applica-
tion with MREC. Unnecessary delays 'caused' by the
length of time taken by research ethics committees to
come to a decision can, of course, add to the cost of a
research project.
Discussion
We start the debate with issues arising from our case study.
This is followed by a wider discussion of the ethical
approval and ethics committees and the implications for
Public Health research in general. It is clear that the four
RECs dealt differently with our application. We had
expected minor variation, based on local circumstances,
but not major procedural differences. RECs A and C did
not appear to re-review the research application in line
with their remit. REC B came back to the research team
with minor observations, which suggests that it had made
ethical considerations where it should only have consid-
ered local circumstances. Its request for guarantees on
medical indemnity is standard practice in clinical
research, but perhaps surprising (unthinking) as our study
did not involve patients at all. Getting ethical approval
from REC D was most cumbersome as it raised issues
apparently outwith their remit.
For a study which did not get close to patients, the process
of applying for research ethics permission took five
months and a lot of work! This extra administrative bur-
den was both time-consuming and frustrating to the
researchers (and the funders).Page 4 of 7
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Our experience highlights several problems inherent in
the current system of area based RECs. First, we found that
local ethics committees operate in very different ways.
Several critiques in the UK have reported a lack of stand-
ardization between research ethics committees in the
ways they process applications [27,35,30]. Many more
have criticized the inconsistency in outcome to the same
application between different RECs [25,26,36]. Unfortu-
nately, we have to agree with Hannigan and Allen [37]
that it is "not clear how far the new UK research govern-
ance framework will help to reduce the unpredictability of
REC decision-making." Moreover, we felt (as a research
team with a small budget, and a strict time scale to pur-
sue) powerless to do anything about how we were being
dealt with, in case it subsequently jeopardised our ability
to conduct the project in the time we had available. We are
aware that inconsistencies in ethical considerations are
not just a UK problem, but also a cross-national one. For
example, Glasziou and Chalmers reported that piloting of
a leaflet aimed at older people to improve GP consulta-
tions needed ethical review, in Belgium, Slovenia and the
UK, but not in Austria, France Germany and Switzerland
[22], whilst the UK has one of the most complicated and
arduous processes [38].
The second consideration concerns resources, especially
staff time needed to complete the application process. We
had believed that taking the time initially to seek MREC
approval would help to speed up the process – but this did
not appear to be the case. Furthermore, there are opportu-
nity costs related to the staff time and salaries required to
consider and respond to applications. A burden borne not
only by the research community, but also by the 'cash-
strapped' health service. Interestingly, only a small pro-
portion of researchers in the study by Richardson and
McMullan [39] commented "that research opportunities
were being lost through the time taken to obtain ethical
approval". Moreover, no one seems to mention the time
of the endless number of volunteers across the UK on
MREC, LRECs, IRBs and NHS Research & Development
committees. RECs can add to the workload of researchers,
and hence the cost of research. One research group calcu-
lated that their ethics application took two weeks to com-
plete and required 44.5 hours of activity at an estimated
cost of £850 [2]. In another example, in one UK clinical
trial, researchers had to submit between one and 21 cop-
ies to each of 125 ethics committees [40].
We also found that the division of labour and jurisdiction
between the MREC and the LRECs was not a distinct as the
regulations suggested. We found that in reply to the same
proposal several LRECs requested that changes were made
on issues which were the jurisdiction of the MREC, not of
the individual LREC.
Academic research considerations
At a wider societal level there are concerns that ethical
governance stifles certain types of low-risk population-
based, epidemiological, health and social service and pub-
lic health research. A classic example case was made by Sir
Richard Doll [41], who argued that the case-control study
in the late 1990s on the link between induced or sponta-
neous abortions and breast cancer [42] would no longer
be possible in the new Millennium. His reason for saying
this relates to the limitations introduced by the 1999 Data
Protection Act which requires that researchers ask patients
for permission to use data collected for a different pur-
pose. Sin reported on a social science study of older peo-
ple from different ethnic minority groups in Britain. This
study was also caught by the introduction of the Data Pro-
tection Act when the relevant UK government body was
no longer permitted to provide a sample [43]. Ethics com-
mittees are directed by the Data Protection Act and similar
legislation for guidance on ethics applications in the clin-
ical research field, which, partly due to standardization,
also cover all other health research.
Professional and academic researchers are currently feel-
ing challenged and beleaguered in their endeavors to
secure research funding and ethical approval [3,4,34,41].
Although there has long been a demand by UK researchers
for improvements in the way RECs operate [26,27,44],
recent changes in the process have not been seen as an
improvement. We would like to highlight recent changes
made by the National Health and Medical Research Coun-
cil in Australia in their National Statement on Ethical Con-
duct in Human Research 2007 which offers different
guidance for "very different types of research" [45]. This
Australian national statement suggests that ethics com-
mittees may establish procedures for expedited review of
research involving minimal risks to participants. It is
unclear how this is going to work in practice, but it incor-
porates some of the worries we have highlighted in this
debate paper.
The researcher is central!
Although research ethics committees can reduce the risk
of unethical research being conducted, they can not pre-
vent it as the various ethical misconducts mentioned
above indicate. We argue that the researcher is central to
the ethical research process. Thus we fully agree with Han-
nigan and Allen [27] that ultimately the responsibility to
ensure that studies are ethically sound lies, where it has
always been, namely with the researchers. Or as Holmes
put it: 'We must trust researchers- as we do physicians and
surgeons 'to do the right thing' [46]. Hence researchers
need to be competent in at least two respects: (1) they
must have research skills; and (2) must be sufficiently
competent to care for the subject [10]. Therefore, we must
educate our students and junior researchers in research
ethics so they too can be trusted to do the right thing.Page 5 of 7
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Ethics committees seem to be expanding their scope and
remit to cover more and more previously uncovered
ground [34]. Making research ethics a bureaucratic tick-
box process can be counterproductive [43,47]. As Barbour
highlighted in her argument against the use of checklists
in qualitative research as we may find we are ending up
with the tail wagging the dog [48]. Or as Richardson and
McMullan noted, it would appear that the UK system of
research ethics governance is in danger of throwing the
baby out with the bath water [4], whilst Dingwall put it
even stronger by suggesting that ethical regulation of low-
risk social research exceeds the harm that the actual
research could do to its participants [49].
One has to ask the question, 'What is the wider societal
problem?' Is there societal demand for increased "safe
guards" to protect against potentially harmful/inappropri-
ate research studies and/or researchers? Or is this a reflec-
tion of inappropriate arduous legislation translation of
the Declaration of Helsinki. Or is it part of a general trend
towards increasing societal control in the UK in general,
including research, e.g. anti-terrorism legislation re. the
call to make everyone carry a national identity cards, or
police checks for every parent volunteer at their child's
school football tournament?
We propose that non-invasive observational studies, i.e.
low-risk population-based health research, including face-
to-face interviews with health and social care profession-
als or postal questionnaire studies with patients on non-
sensitive topics are given a waiver or a light touch review.
Perhaps this can be achieved by the introduction of a two-
staged ethics application process. First, a preliminary stage
with a short one or two-page outline application which
LRECs can use as the basis to grant a waiver, and secondly
a full application for those projects not deemed to be at
low-risk. Drug companies and researchers planning to
conduct invasive interventions may skip the preliminary
application and proceed directly to the full-application
stage.
Ethical regulation has become cumbersome and time con-
suming [21], and starts to act as a barrier to low-risk pop-
ulation-based health research and the progress of
expanding our knowledge in this field. Knowledge, which
as Cochrane reviews (see: http://www.cochrane.org/
reviews/) often tells us, is often lacking for community-
based health promotion and public health interventions.
We would like to share our experiences with readers of
this journal to stimulate a debate, with the aim of drawing
attention to the plight of those engaged in low-risk public
health research and evaluation – which must be con-
ducted in line with research governance guidelines – but
at the same time, is often done so in the context of scant
or no resources.
Summary
1. Having one general research ethics application form
originally designed for clinical and pharmacological
research for all types of low-risk research, leads to over-
regulation and the inappropriate application of a biomed-
ical framework.
2. Balance the needs of researchers in their quest to con-
duct high quality research and the protection of individ-
ual study participants, as applying rigid approaches to
research ethics guidelines could severely restrict progress
in vital population-based studies.
3. Ethics committees should appraise the risk from
research projects aimed designed for (a) individual
patient-based pharmaceutical and surgical interventions;
(b) population-based, anonymous health and social serv-
ices and health promotion research; and (c) studies of
ordinary people, (i.e. non-patients) and staff.
4. Non-invasive low-risk studies such as face-to-face inter-
views with health and social care professionals or postal
questionnaire studies with patients on non-sensitive top-
ics are given a waiver or a light touch review. This can be
achieved by a two-staged ethics application process, a pre-
liminary stage with a short outline application on the
basis of which LRECs can grant a waiver or request a full
application.
5. It is important to train junior researchers and students
about their role in setting and maintaining ethical stand-
ards in research.
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